Regeneron Pharmaceuticals Ownership | Who Owns Regeneron Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Regeneron Pharmaceuticals Ownership Summary


Regeneron Pharmaceuticals is owned by 84.97% institutional investors, 1.93% insiders, and 13.10% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.83% of REGN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in Regeneron Pharmaceuticals shares.

REGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRegeneron Pharmaceuticals84.97%1.93%13.10%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.28M8.83%$4.87B
Vanguard group9.29M8.59%$6.61B
Blackrock8.45M7.84%$8.88B
Fmr8.20M7.59%$5.84B
Jpmorgan chase7.06M6.53%$5.03B
State street4.84M4.49%$5.09B
Dodge & cox3.83M3.64%$2.01B
Capital investors3.17M3.01%$1.66B
Geode capital management2.43M2.25%$1.73B
Price t rowe associates inc /md/2.09M1.93%$1.49B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bronte capital management pty187.87K8.73%$111.08M
R.p. boggs29.68K7.92%$15.58M
Mcdonald capital investors inc/ca218.04K7.18%$114.47M
Rk asset management12.60K6.38%$6.62M
Orion investment30.27K5.63%$15.89M
Solas capital management18.59K5.46%$9.76M
Southeastern asset management inc/tn/160.58K4.25%$84.31M
Guoline advisory pte46.36K3.41%$33.02M
Seaport global advisors839.003.16%$881.81K
Evergreen wealth management10.44K3.07%$5.48M

Top Buyers

HolderShares% AssetsChange
Dodge & cox3.83M1.13%1.50M
Norges bank1.13M0.11%1.13M
Price t rowe associates inc /md/2.09M0.17%810.14K
Blackrock funding, inc. /de9.28M0.09%350.20K
Acadian asset management465.74K0.50%326.58K

Top Sellers

HolderShares% AssetsChange
Fmr8.20M0.35%-2.16M
Capital investors3.17M0.29%-823.87K
Amundi897.13K0.17%-706.77K
Jpmorgan chase7.06M0.37%-430.13K
Invesco864.25K0.11%-296.92K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.13M0.11%1.13M$802.04M
Point72 asset management143.11K0.15%143.11K$75.13M
Quadrature capital70.45K0.64%70.45K$36.97M
Integral health asset management50.00K2.40%50.00K$26.25M
Lmr partners llp43.64K0.16%43.64K$22.91M

Sold Out

HolderChange
Proffitt & goodson-1.00
Greenline partners-1.00
Triad wealth partners-1.00
Financial gravity asset management-1.00
Coastline trust-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251,254-5.93%89,298,391-2.58%841.15%562-14.07%4692.85%
Mar 31, 202518-98.69%558,121-99.40%-0.01%7-98.90%3-99.38%
Dec 31, 20241,243-13.68%85,658,993-7.35%791.08%578-12.82%435-4.81%
Sep 30, 20241,4162.98%92,708,421-1.26%851.14%652-1.06%4484.92%
Jun 30, 20241,358-0.29%93,841,3672.15%871.20%6504.67%422-5.59%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.34M3.15%-77.26K
Vanguard US Total Market Shares ETF3.44M3.14%178.74K
Vanguard Institutional 500 Index Trust2.99M2.77%22.25K
Vanguard 500 Index Investor2.57M2.43%-376.58K
Dodge & Cox Stock I2.49M2.31%937.70K
Invesco QQQ Trust2.18M2.05%-1.37K
Fidelity Contrafund1.65M1.56%-269.91K
Fidelity 500 Index1.32M1.24%-11.49K
SPDR® S&P 500 ETF1.31M1.20%-19.22K
SPDR® S&P 500® ETF1.26M1.19%-5.25K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 01, 2024McCourt Marion EVP CommercialSell$844.61K
Oct 01, 2024RYAN ARTHUR F-Sell$5.22K
Oct 01, 2024RYAN ARTHUR F-Sell$9.40K
Oct 01, 2024RYAN ARTHUR F-Sell$7.32K
Oct 01, 2024RYAN ARTHUR F-Sell$1.04K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4-19
2024 Q3-117
2024 Q2-113
2024 Q1-116

REGN Ownership FAQ


Who Owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals shareholders are primarily institutional investors at 84.97%, followed by 1.93% insiders and 13.10% retail investors. The average institutional ownership in Regeneron Pharmaceuticals's industry, Biotech Stocks , is 304.14%, which Regeneron Pharmaceuticals falls below.

Who owns the most shares of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (9.28M shares, 8.83%), Vanguard group (9.29M shares, 8.59%), and Blackrock (8.45M shares, 7.84%). Together, they hold 25.25% of Regeneron Pharmaceuticals’s total shares outstanding.

Does Blackrock own Regeneron Pharmaceuticals?

Yes, BlackRock owns 7.84% of Regeneron Pharmaceuticals, totaling 8.45M shares as of Jun 2024. This represents 0.20% of BlackRock's total assets, with a market value of 8.88B$. In the last quarter, BlackRock decreased its holdings by -122K shares, a -1.43% change.

Who is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bronte capital management pty is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.73% of its assets in 187.87K Regeneron Pharmaceuticals shares, valued at 111.08M$.

Who is the top mutual fund holder of Regeneron Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Regeneron Pharmaceuticals shares, with 3.15% of its total shares outstanding invested in 3.34M Regeneron Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools